RSS Atom • ISSN 1472-4683 • Subscribe • About
Antiretrovirals
- Spray-dried nanoparticle formulation of efavirenz Antiretrovirals - Conference reports - World AIDS 18 Vienna 2010 - 1 October 2010
- Switching boosted-PIs to raltegravir Antiretrovirals - Conference reports - Treatment strategies - World AIDS 18 Vienna 2010 - 1 October 2010
- Early infant diagnosis Antiretrovirals - Conference reports - Diagnostics - Paediatric care - World AIDS 18 Vienna 2010 - 1 October 2010
- Efavirenz-based regimens among women of reproductive age receiving ART in Johannesburg Antiretrovirals - Conference reports - PMTCT and maternal health - Women's health - World AIDS 18 Vienna 2010 - 1 October 2010
- Saquinavir prolongation of QT interval: Roche issue Dear Doctor letter Antiretrovirals - 1 October 2010
- Development of chronic kidney disease and antiretroviral use in EuroSIDA cohort since 2004 Antiretrovirals - Side effects - 1 October 2010
- Rilpivirine (TMC-278) vs efavirenz in treatment-naïve patients: phase 3 results Antiretrovirals - Conference reports - World AIDS 18 Vienna 2010 - 26 August 2010
- Once-daily nevirapine extended release (XR) is non-inferior to current formulation Antiretrovirals - Conference reports - World AIDS 18 Vienna 2010 - 26 August 2010
- GSK572 (dolutegravir): second-generation integrase inhibitor Antiretrovirals - Conference reports - World AIDS 18 Vienna 2010 - 26 August 2010
- TBR-652: early results for CCR5 inhibitor Antiretrovirals - Conference reports - World AIDS 18 Vienna 2010 - 26 August 2010
- Atazanavir/r plus maraviroc or tenofovir/FTC in treatment-naïve patients Antiretrovirals - Conference reports - World AIDS 18 Vienna 2010 - 26 August 2010
- Unboosted twice-daily atazanavir plus raltegravir Antiretrovirals - Conference reports - World AIDS 18 Vienna 2010 - 26 August 2010
- CASCADE analysis of when to start treatment Antiretrovirals - Conference reports - World AIDS 18 Vienna 2010 - 26 August 2010
- Impact of antiretroviral PMTCT prophylaxis regimens on subsequent maternal disease progression in Kesho Bora Antiretrovirals - Conference reports - PMTCT and maternal health - World AIDS 18 Vienna 2010 - 26 August 2010
- Birth outcomes with antiretroviral exposure Antiretrovirals - Conference reports - PMTCT and maternal health - World AIDS 18 Vienna 2010 - 26 August 2010
- No difference in outcomes for children initiating treatment with a protease inhibitor or an NNRTI nor with viral load switching strategies in PENPACT-1 Antiretrovirals - Conference reports - Paediatric care - World AIDS 18 Vienna 2010 - 26 August 2010
- Tablets more acceptable than syrups in the ARROW trial Antiretrovirals - Conference reports - Paediatric care - Treatment strategies - World AIDS 18 Vienna 2010 - 26 August 2010
- Paediatric formulation of TMC 278 Antiretrovirals - Conference reports - Paediatric care - 26 August 2010
- Atazanavir/r approved in Europe for children aged 6 to 18 years Antiretrovirals - Paediatric care - Treatment access - 26 August 2010
- FDA finally approves 4th generation HIV Ag/Ab test in the US Antiretrovirals - Diagnostics - PMTCT and maternal health - Paediatric care - Treatment access - 26 August 2010
- START study launched and endorsed by broad community support: over 140 community organisations sign letter to US guideline panel Antiretrovirals - 1 June 2010
- Treatment reduces infections by over 90%: a theme that is here to stay Antiretrovirals - Conference reports - Transmission and prevention - CROI 17 (Retrovirus) 2010 - 2 April 2010
- ACTG 5205: atazanavir/ritonavir vs efavirenz in treatment naïve patients Antiretrovirals - Conference reports - Lipodystrophy and metabolic complications - Side effects - CROI 17 (Retrovirus) 2010 - 2 April 2010
- Pipeline compounds and new approaches to treatment Antiretrovirals - Conference reports - CROI 17 (Retrovirus) 2010 - 2 April 2010
- FDA safety review of saquinavir (Invirase) and possible association with abnormal heart rhythms Antiretrovirals - 2 April 2010
- FDA safety announcement about ddI and non-cirrhotic portal hypertension Antiretrovirals - 2 April 2010
- Once-daily darunavir/r monotherapy is suboptimal as initial regimen in treatment-naïve people Antiretrovirals - Conference reports - EACS 12 Cologne 2009 - 21 February 2010
- GSK issues Dear Doctor letter in the US: fosamprenavir and cardiovascular risk Antiretrovirals - Side effects - 16 February 2010
- Recent ARVs and the blood/brain barrier: CSF drug concentrations of darunavir/r and raltegravir Antiretrovirals - Conference reports - ICAAC 49th San Fransisco 2009 - 31 December 2009
- Tibotec issues Dear Doctor letter in Europe concerning severe etravirine reactions: three case reports Antiretrovirals - Treatment alerts - 30 December 2009
- First results of new integrase compound: GSK1349572 Antiretrovirals - Conference reports - IAS 5 Cape Town 2009 - 5 October 2009
- Raltegravir in treatment-naive patients Antiretrovirals - Conference reports - IAS 5 Cape Town 2009 - 5 October 2009
- Nevirapine vs atazanavir/ritonavir in treatment-naive patients: ARTEN study Antiretrovirals - Conference reports - IAS 5 Cape Town 2009 - 5 October 2009
- Darunavir/r monotherapy studies Antiretrovirals - Conference reports - IAS 5 Cape Town 2009 - 5 October 2009
- Maraviroc results similar to efavirenz when analysed using more sensitive tropism test Antiretrovirals - Conference reports - IAS 5 Cape Town 2009 - 5 October 2009
- Maximal suppression achieved with three drugs: no additional virological impact of raltegravir intensification Antiretrovirals - Conference reports - IAS 5 Cape Town 2009 - 5 October 2009
- CD4 responses after viral suppression for more than 7 years on HAART Antiretrovirals - 5 October 2009
- 50mg and 100mg ritonavir doses achieve similar levels of saquinavir in Thai patients Antiretrovirals - 5 October 2009
- Etravirine (Intelence) label change in the US due to severe hypersensitivity reactions Antiretrovirals - 2 October 2009
- Four weeks lopinavir/r to cover functional monotherapy when stopping HAART Antiretrovirals - Conference reports - PK Workshop 10th 2009 - 23 August 2009
- Efavirenz-related studies: genetics, smoking and TDM Antiretrovirals - Conference reports - PK Workshop 10th 2009 - 23 August 2009
- Atazanavir: a suitable case for TDM? Antiretrovirals - Conference reports - PK Workshop 10th 2009 - 23 August 2009
- Raltegravir approved in the US for treatment-naive patients: paranoia and anxiety added as side effects Antiretrovirals - 22 August 2009
- EMEA positive opinion on using tipranavir and darunavir in younger patients Antiretrovirals - 3 June 2009
- NA ACCORD results support the importance of the START study: response to researchers Antiretrovirals - 3 June 2009
- Increased atazanavir dose recommended when used in combination with efavirenz or Atripla in naive patients Antiretrovirals - 19 February 2009
- Summary of antiretroviral studies at Glasgow Antiretrovirals - Conference reports - HIV 9 Glasgow 2008 - 18 February 2009
- EMEA approves once-daily darunavir/ritonavir (800mg/100mg) for treatment-naive patients in Europe Antiretrovirals - 10 February 2009
- Maraviroc safety label changes included with US traditional approval Antiretrovirals - 9 February 2009
- EMEA supports extension of D:A:D study until at least 2012 and the new remit to include non-AIDS cancers and kidney disease Antiretrovirals - Cancer and HIV - 9 February 2009
- Applications to approve non-refrigerated ritonavir submitted to EMEA and FDA Antiretrovirals - 9 February 2009
- Studies of pipeline drugs: RDEA806, PRO140, bevirimat, elvucitabine Antiretrovirals - Conference reports - ICAAC 48th Washington 2008 - 26 December 2008
- Other antiretroviral studies at ICAAC Antiretrovirals - Conference reports - ICAAC 48th Washington 2008 - 26 December 2008
- Non alcoholic fatty liver disease (NAFLD) is common among HIV-positive patients Antiretrovirals - Conference reports - ICAAC 48th Washington 2008 - 26 December 2008
- US revisions to darunavir label include once-daily indication for naïve patients Antiretrovirals - 26 December 2008
- Baseline renal insufficiency and mortality risk in HIV-positive adults in Zambia Antiretrovirals - 26 December 2008
- Inflammatory and coagulation biomarkers linked to mortality in large treatment interruption trial Antiretrovirals - 26 December 2008
- Abacavir and heart disease: SMART study supports an abacavir-associated increased risk of cardiovascular disease Antiretrovirals - Conference reports - Side effects - World AIDS 17 Mexico City 2008 - 30 October 2008
- EMEA state that animal studies support no increased risk of malignancy from contamination of nelfinavir (Viracept) with ethyl mesilate (EMS) Antiretrovirals - Side effects - 30 October 2008
- Abacavir label updated in the US on use of B-5701 testing and cardiovascular risk Antiretrovirals - 30 October 2008
- Ritonavir label updated in the US relating to cardiac arrhythmia reported in high-dose studies Antiretrovirals - Side effects - 30 October 2008
- Atazanavir label updated in the US relating to drug interactions with NNTRIs, hormonal contraceptives, midazolam, H2 receptor antagonists and other drugs Antiretrovirals - 30 October 2008
- Pipeline antiretrovirals: IDX899, CHX157 and bevirimat Antiretrovirals - Conference reports - Intl Drug Resistance Workshop 17 Sitges 2008 - 30 August 2008
- Renal tubular dysfunction with tenofovir-based HAART in four vertically infected adolescents Antiretrovirals - Conference reports - BHIVA 14th Belfast 2008 - 30 August 2008
- BMS and Merck discontinue 100mg capsule formulation of efavirenz used for paediatric treatment Antiretrovirals - 30 August 2008
- Saquinavir (Invirase) interactions with digoxin, garlic capsules, methadone, tipranavir and omeprazole: US label changes Antiretrovirals - 30 August 2008
- Tibotec issue Dear Doctor letter and FDA require darunavir label change relating to hepatotoxicity Antiretrovirals - 12 June 2008
- Abacavir, ddI and risk of heart attack: additional published data and statements from the EMEA and FDA Antiretrovirals - 1 June 2008
- Atazanavir/r vs lopinavir/r in treatment-naïve patients: 48 week results Antiretrovirals - Conference reports - CROI 15 (Retrovirus) 2008 - 1 April 2008
- US study changes use of abacavir/3TC in naïve patients with viral load >100,000 copies based on DSMB recommendation Antiretrovirals - 1 April 2008